Company / Capital Expenditures
Medpace Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$31.4M
FY2025
5-year range
$28.3M / $36.6M
FY2021-FY2025
Trend
-14.2%
vs FY2024
Sector context
#95 of 151
Health Care
What the data says
At $31M, Medpace's capital expenditures ranks #95 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $12M in FY2017 to $37M in FY2023.
Based on SEC 10-K filings.
$31M in FY2025 with a 5-year CAGR of +0.0%.
Declined from $37M to $31M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
#95 of 151 in Health CareTop 63% of 151This company $31.4M Sector average $271.7M
▼
-88.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.0%, indicating consistent growth.
- In FY2025, capital expenditures decreased 14.2% year-over-year.
- Ranks #95 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.4M | -14.2% |
| FY2024 | $36.5M | -0.3% |
| FY2023 | $36.6M | +16.9% |
| FY2022 | $31.3M | +10.9% |
| FY2021 | $28.3M | -9.8% |
| FY2020 | $31.3M | +75.0% |
| FY2019 | $17.9M | +32.3% |
| FY2018 | $13.5M | +15.5% |
| FY2017 | $11.7M | -13.4% |
| FY2016 | $13.5M | +109.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026